Drug: Paclitaxel to Treat NSCLC

Paclitaxel (Taxol)In the past two decades, little progress has been made in the field of lung cancer treatment. Patients with advanced level of cancer find it difficult to survive. Non-small cell lung cancer is a leading cause of cancer deaths worldwide. A relatively new cytostatic drug for the treatment of non small cell lung cancer is Paclitaxel. It is one of the commonly used agents in treatment of patients with advanced and metastatic non small cell lung cancer.

How Paclitaxel Works?

The combination of paciltaxel and platinum compound is approved for treatment of NSCLC. This drug has demonstrated synergistic interaction with several molecularly-targeted agents. This anti-cancer chemotherapy drug is given into a vein. It is generally given with other treatments. It works by stopping cancer cells from separating into two new cells. This leads to blockage of the growth of cancer.

Paclitaxel Albumin-stabilized Nanoparticle Formulation

Dosage and Side Effects

As far as the dosage is concerned, it is usually given once in every three weeks.  With use of such regimes in the earlier stages of non-small cell lung cancer, most patients are offered chemotherapy as a part of overall program. Some of the common side effects of Paclitaxel include feeling unwell or having temperature. You should contact your doctor if you face serious side effects or how to manage these side effects.

Precautions to be Taken

These cancer drugs may interact with other medicines and herbal products. It is important to not to become pregnant or father a child during the lung cancer treatment. Breastfeeding is also not allowed as the drug may come through in the breast milk. You should also inform your doctor about other treatment you are going through at the same time.

The information shared in this blog is for educational purposes. If you face any cancer related symptoms, contact your health care provider.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.